Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors.

IF 1.4 4区医学 Q4 CELL BIOLOGY

Cell and Tissue Banking Pub Date : 2023-09-01 DOI:10.1007/s10561-022-10054-0

Melissa A Greenwald, Eduard Grebe, Valerie Green, Alyce Linthurst Jones, Jeffrey M Linnen, Phillip Williamson, Michael P Busch, Matthew J Kuehnert

{"title":"Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors.","authors":"Melissa A Greenwald, Eduard Grebe, Valerie Green, Alyce Linthurst Jones, Jeffrey M Linnen, Phillip Williamson, Michael P Busch, Matthew J Kuehnert","doi":"10.1007/s10561-022-10054-0","DOIUrl":null,"url":null,"abstract":"<p><p>Given the possibility for disease transmission, this study was performed to determine whether there is detectable SARS-CoV-2 viral RNA in the blood of deceased tissue donors. A retrospective analysis of blood samples from eligible deceased tissue donors from Oct 2019 through June 2020 was performed. Plasma aliquots were initially tested with a SARS-CoV-2 NAT Assay; positive samples were further tested using an alternate NAT and an antibody assay. The proportion of donors with confirmed RNAemia and 95% confidence intervals were computed. Of donor samples collected in 2019, 894 yielded valid results, with 6 initially positive, none of which confirmed positive by alternate NAT. Of donor samples collected in 2020, 2562 yielded valid initial NAT results, with 21 (0.8%) initially positive. Among those, 3 were confirmed by alternate NAT, 17 were not confirmed, and 1 had an invalid alternate NAT result. The rate of SARS-CoV-2 RNAemia in deceased tissue donors is approximately 1 per 1000, and it is unknown whether this RNAemia reflects the presence of infectious virus. Given these results, the risk of transmission through tissue is thought likely to be low.</p>","PeriodicalId":9723,"journal":{"name":"Cell and Tissue Banking","volume":"24 3","pages":"585-596"},"PeriodicalIF":1.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734833/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell and Tissue Banking","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1007/s10561-022-10054-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CELL BIOLOGY","Score":null,"Total":0}

引用次数: 1

Abstract

Given the possibility for disease transmission, this study was performed to determine whether there is detectable SARS-CoV-2 viral RNA in the blood of deceased tissue donors. A retrospective analysis of blood samples from eligible deceased tissue donors from Oct 2019 through June 2020 was performed. Plasma aliquots were initially tested with a SARS-CoV-2 NAT Assay; positive samples were further tested using an alternate NAT and an antibody assay. The proportion of donors with confirmed RNAemia and 95% confidence intervals were computed. Of donor samples collected in 2019, 894 yielded valid results, with 6 initially positive, none of which confirmed positive by alternate NAT. Of donor samples collected in 2020, 2562 yielded valid initial NAT results, with 21 (0.8%) initially positive. Among those, 3 were confirmed by alternate NAT, 17 were not confirmed, and 1 had an invalid alternate NAT result. The rate of SARS-CoV-2 RNAemia in deceased tissue donors is approximately 1 per 1000, and it is unknown whether this RNAemia reflects the presence of infectious virus. Given these results, the risk of transmission through tissue is thought likely to be low.

Abstract Image

查看原文本刊更多论文

死亡组织供体中SARS-CoV-2 RNA检出率低。

考虑到疾病传播的可能性，本研究旨在确定死亡组织捐献者的血液中是否存在可检测到的SARS-CoV-2病毒RNA。对2019年10月至2020年6月符合条件的已故组织捐献者的血液样本进行了回顾性分析。最初用SARS-CoV-2 NAT Assay检测血浆等分液;阳性样本进一步使用替代NAT和抗体试验进行检测。计算确诊RNAemia的供者比例和95%置信区间。在2019年收集的供体样本中，894个产生了有效结果，其中6个初始阳性，没有一个通过替代NAT确认阳性。在2020年收集的供体样本中，2562个产生了有效的初始NAT结果，其中21个(0.8%)初始阳性。其中3个被备用NAT确认，17个未被确认，1个无效的备用NAT结果。死亡组织供体中SARS-CoV-2核糖核酸血症的发生率约为千分之一，目前尚不清楚这种核糖核酸血症是否反映了传染性病毒的存在。鉴于这些结果，通过组织传播的风险被认为可能很低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell and Tissue Banking CELL BIOLOGY-ENGINEERING, BIOMEDICAL

CiteScore

3.10

自引率

13.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Cell and Tissue Banking provides a forum for disseminating information to scientists and clinicians involved in the banking and transplantation of cells and tissues. Cell and Tissue Banking is an international, peer-reviewed journal that publishes original papers in the following areas: basic research concerning general aspects of tissue banking such as quality assurance and control of banked cells/tissues, effects of preservation and sterilisation methods on cells/tissues, biotechnology, etc.; clinical applications of banked cells/tissues; standards of practice in procurement, processing, storage and distribution of cells/tissues; ethical issues; medico-legal issues.